產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務熱線
NIH:OVCAR-3 [OVCAR3] (人卵巢癌細胞) (STR鑒定正確)
貨號:CL-0178
規(guī)格:1×10?cells/T25培養(yǎng)瓶
價格: ¥2000
生長培養(yǎng)基:RPMI-1640+20% FBS+10μg/mL Insulin+1% P/S
產(chǎn)品概述
名稱 | NIH:OVCAR-3 [OVCAR3] (人卵巢癌細胞) (STR鑒定正確) |
別稱 | Ovcar-3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR.3; OVCAR3; Ovcar3 |
種屬 | 人 |
生長特性 | 貼壁細胞 |
細胞形態(tài) | 上皮細胞樣 |
凍存條件 | 凍存液:55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認) |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | NIH:OVCAR-3 [OVCAR3]細胞是由T·C·Hamilton在1982年建系,NIH:OVCAR-3 [OVCAR3]細胞取材于患進行性卵巢腺癌病人的惡性腹水。在裸鼠皮下接種 1×10^7細胞,21天后全部成瘤。NIH:OVCAR-3 [OVCAR3]細胞是研究卵巢癌藥物抗性的一個合適的模型系統(tǒng)且由于存在激素受體,這對于激素治療的評估或許是有用的。 |
年齡(性別) | 女性;60歲 |
組織來源 | 卵巢腺癌 |
細胞類型 | 腫瘤細胞 |
腫瘤類型 | 卵巢癌細胞 |
生物安全等級 | BSL-1 |
倍增時間 | ~35-64 hours |
致瘤性 | Yes, Forms colonies in soft agar.Yes, in nude mice inoculated subcutaneously with 1×10^7 cells (Tumors developed within 21 days at 100% frequency (5/5)). |
受體表達情況 | Androgen receptor, positive;estrogen receptor, positive;progesterone receptor, positive |
保藏機構 | ATCC; HTB-161 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 11,12 D2S1338 17,21 D3S1358 17,18 D5S818 11,12 D7S820 10 D8S1179 10,15 D13S317 12 D16S539 12 D18S51 13 D19S433 14,16.2 D21S11 29,31.2 FGA 21 PentaD 12,13 PentaE 7,13 TH01 9 TPOX 8 vWA 17 D6S1043 10,11 D12S391 19,22 D2S441 11,14 -
STR鑒定圖
-
參考文獻
-
PLIN2 Promotes Lipid Accumulation in Ascites-Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling (2025-02-07)
期刊:Advanced Science
影響因子 :14.3
引用產(chǎn)品: U-937 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , 特級胎牛血清 , 重組人胰島素溶液(10 mg/mL) , SK-OV-3 細胞 , McCoy's 5A 培養(yǎng)基 , THP-1 細胞
-
Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies (2025-01-17)
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2024.1500153
影響因子 :5.7
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞
-
Discovery of a selective and reversible LSD1 inhibitor with potent anticancer effects in vitro and in vivo (2025-02-20)
期刊:JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
DOI:10.1080/14756366.2025.2466093
影響因子 :5.6
引用產(chǎn)品: PC-3 細胞 , Caco-2 細胞 , Hep G2 細胞 , Hep 3B2.1-7 細胞 , HuH-6 細胞 , HuH-7 細胞 , MCF7 [MCF-7] 細胞 , HL-60 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , A549 [A-549] 細胞
-
Iodinated Copper–Cysteamine Nanoparticles as Radiosensitizers for Tumor Radiotherapy (2025-01-22)
期刊:Pharmaceutics
DOI:10.3390/pharmaceutics17020149
影響因子 :4.9
引用產(chǎn)品: ID8 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , A2780 細胞
-
ACSM3 Suppresses Ovarian Cancer Progression by Inactivating the IFN-γ/JAK/STAT3 Signaling Pathway (2025-02-06)
期刊:Advanced Biology
影響因子 :3.2
引用產(chǎn)品: 人口腔上皮細胞 , Caov-3 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , 人卵巢上皮細胞完全培養(yǎng)基 , 青霉素-鏈霉素溶液(雙抗),100× , McCoy's 5A 培養(yǎng)基 , RPMI-1640 培養(yǎng)基 , 重組人胰島素溶液(10 mg/mL)
-
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer (2024-02-26)
期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI:10.1186/s13046-024-02981-5
影響因子 :11.3
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞 , McCoy's 5A 培養(yǎng)基
-
MIR937 amplification potentiates ovarian cancer progression by attenuating FBXO16 inhibition on ULK1-mediated autophagy (2024-10-09)
期刊:Cell Death & Disease
DOI:10.1038/s41419-024-07120-8
影響因子 :8.1
引用產(chǎn)品: A2780 細胞 , TOV21G 細胞 , SK-OV-3 細胞 , 293T [HEK-293T] 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway (2024-01-29)
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-024-04929-x
影響因子 :7.4
引用產(chǎn)品: A2780 細胞 , Caov-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞 , IOSE80 細胞
-
USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2 (2024-09-10)
期刊:ONCOGENE
DOI:10.1038/s41388-024-03151-9
影響因子 :6.9
引用產(chǎn)品: 293T [HEK-293T] 細胞 , SK-OV-3 細胞 , Caov-3 細胞 , A2780 細胞 , Hey 細胞 , SW626 細胞 , ES-2 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
Dietary flavonoid tectochrysin synergistically enhances cisplatin sensitivity on ovarian cancer cells through targeting the CDK1/cyclin B1 pathway (2024-05-21)
期刊:Journal of Functional Foods
影響因子 :5.6
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , A2780 細胞 , SK-OV-3 細胞
-
Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53 (2024-02-04)
期刊:MOLECULES
影響因子 :4.6
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞
-
SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway (2024-08-20)
期刊:Translational Oncology
DOI:10.1016/j.tranon.2024.102088
影響因子 :4.5
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , ES-2 細胞
-
Micellar curcumol for maintenance therapy of ovarian cancer by activating the FOXO3a (2024-10-01)
期刊:Nanomedicine-Nanotechnology Biology and Medicine
DOI:10.1016/j.nano.2024.102789
影響因子 :4.2
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞
-
Ubiquitin ligase TRIM22 inhibits ovarian cancer malignancy via TCF4 degradation (2024-06-06)
期刊:MOLECULAR CANCER RESEARCH
DOI:10.1158/1541-7786.MCR-23-0962
影響因子 :4.1
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells (2024-03-27)
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-024-01393-5
影響因子 :4.0
引用產(chǎn)品: Annexin V Binding Buffer (1×) , SK-OV-3 細胞 , Hey 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , A2780 細胞 , ES-2 細胞 , HO-8910 細胞 , IOSE-80 細胞
-
Squalene monooxygenase (SQLE) protects ovarian cancer cells from ferroptosis (2024-09-30)
期刊:Scientific Reports
DOI:10.1038/s41598-024-72506-9
影響因子 :3.8
引用產(chǎn)品: SK-OV-3 細胞 , IOSE-80 細胞 , A2780 細胞 , Hey 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , ES-2 細胞 , HO-8910 細胞
-
Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway (2024-12-19)
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-024-01570-6
影響因子 :3.8
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1 (2024-04-08)
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2024.114006
影響因子 :3.7
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞 , Hey 細胞
-
MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo (2024-01-08)
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2024.113913
影響因子 :3.7
引用產(chǎn)品: Anglne 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
Comprehensive analysis of ferroptosis-related genes indicates that TRIM46 is a novel biomarker and promotes the progression of ovarian cancer via modulating ferroptosis and Wnt signaling pathway (2024-10-15)
期刊:American Journal of Cancer Research
影響因子 :3.6
引用產(chǎn)品: Caov-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , SNU-8 細胞 , IOSE80 細胞
-
RNA-binding protein THUMPD2 inhibits proliferation and promotes metastasis in epithelial ovarian cancer (2024-06-24)
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e33201
影響因子 :3.4
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞
-
hsa_circ_0000129 targets miR-383-5p/tropomyosin 3 axis to facilitate ovarian cancer progression (2024-09-01)
期刊:BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
DOI:10.1002/bab.2643
影響因子 :3.2
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , McCoy's 5A 培養(yǎng)基 , DMEM高糖 培養(yǎng)基 , RPMI-1640 培養(yǎng)基 , Caov-3 細胞 , 青霉素-鏈霉素溶液(雙抗),100× , SK-OV-3 細胞
-
A disulfidptosis-related lncRNAs cluster to forecast the prognosis and immune landscapes of ovarian cancer (2024-07-09)
期刊:Frontiers in Genetics
DOI:10.3389/fgene.2024.1397011
影響因子 :2.8
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , 青霉素-鏈霉素溶液(雙抗),100× , 重組人胰島素溶液(10 mg/mL)
-
Suppression of KLF5 targets RREB1 to restrain the proliferation of ovarian cancer cells through ERK/MAPK signaling pathway (2024-12-11)
期刊:3 Biotech
DOI:10.1007/s13205-024-04171-8
影響因子 :2.6
引用產(chǎn)品: A2780 細胞 , HO-8910 細胞 , SK-OV-3 細胞 , ES-2 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , CoC1 細胞
-
KDM1A-mediated ZFP64 demethylation activates CENPL to promote epithelial ovarian cancer progression (2024-12-01)
期刊:CYTOTECHNOLOGY
DOI:10.1007/s10616-024-00671-w
影響因子 :2.0
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞 , RPMI-1640 培養(yǎng)基 , SK-OV-3 細胞 , McCoy's 5A 培養(yǎng)基
-
CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer (2024-06-12)
期刊:JOURNAL OF OBSTETRICS AND GYNAECOLOGY
DOI:10.1080/01443615.2024.2363515
影響因子 :0.9
引用產(chǎn)品: Caov-3 細胞 , Anglne 細胞 , 人卵巢上皮細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression (2023-10-12)
期刊:CELL DEATH AND DIFFERENTIATION
DOI:10.1038/s41418-023-01226-w
影響因子 :12.4
引用產(chǎn)品: 293T [HEK-293T] 細胞 , SK-OV-3 細胞 , Caov-3 細胞 , A2780 細胞 , Hey 細胞 , SW626 細胞 , Anglne 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM) (2023-04-22)
期刊:Journal of Ovarian Research
DOI:10.1186/s13048-023-01156-8
影響因子 :4.0
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , ES-2 細胞 , A2780 細胞
-
Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives (2023-11-27)
期刊:CANCER BIOLOGY & THERAPY
DOI:10.1080/15384047.2023.2285817
影響因子 :3.6
引用產(chǎn)品: A2780 細胞 , Caov-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞 , IOSE80 細胞
-
ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer (2023-11-03)
期刊:PATHOLOGY RESEARCH AND PRACTICE
影響因子 :2.8
引用產(chǎn)品: A2780 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3 (2023-02-01)
期刊:Recent Patents on Anti-Cancer Drug Discovery
DOI:10.2174/1574892817666220316152201
影響因子 :2.8
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , A2780 細胞 , HO-8910 細胞 , 人卵巢上皮細胞
-
Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in Ovarian Cancer (2023-07-01)
期刊:CURRENT PHARMACEUTICAL BIOTECHNOLOGY
DOI:10.2174/1389201023666221011115301
影響因子 :2.8
引用產(chǎn)品: A2780 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清 , 增強型細胞活力檢測試劑盒(CCK-8) , Annexin V-FITC/PI熒光雙染細胞凋亡檢測試劑盒
-
MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer (2023-06-14)
期刊:Discover Oncology
DOI:10.1007/s12672-023-00705-3
影響因子 :2.2
引用產(chǎn)品: IOSE80 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , SK-OV-3 細胞
-
Down-regulation of DPP4 by TGFβ1/miR29a-3p inhibited proliferation and promoted migration of ovarian cancer cells (2023-10-31)
期刊:Discover Oncology
DOI:10.1007/s12672-023-00815-y
影響因子 :2.2
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis (2022-10-22)
期刊:CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI:10.1186/s11658-022-00364-2
影響因子 :8.7
引用產(chǎn)品: Hey 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , 人臍靜脈內(nèi)皮細胞 , 人臍靜脈內(nèi)皮細胞完全培養(yǎng)基
-
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib (2022-09-05)
期刊:Oxidative Medicine and Cellular Longevity
影響因子 :7.3
引用產(chǎn)品: A2780 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , ES-2 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清 , McCoy's 5A 培養(yǎng)基 , 增強型細胞活力檢測試劑盒 (CCK-8) , 碘化丙啶 (PI)染色液 (50μg/mL)
-
Norcantharidin induces ferroptosis via the suppression of NRF2/HO?1 signaling in ovarian cancer cells (2022-08-25)
期刊:Oncology Letters
影響因子 :3.1
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells (2022-12-05)
期刊:Reproductive Biology
DOI:10.1016/j.repbio.2022.100704
影響因子 :2.1
引用產(chǎn)品: SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , A2780 細胞 , ES-2 細胞 , 293T [HEK-293T] 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清 , 青霉素-鏈霉素溶液 (雙抗),100×
-
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression (2021-06-17)
期刊:Biomedicine & Pharmacotherapy
DOI:10.1016/j.biopha.2021.111533
影響因子 :7.5
引用產(chǎn)品: CoC1 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , RPMI-1640 培養(yǎng)基 , McCoy's 5A 培養(yǎng)基
-
P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway (2021-08-12)
期刊:Cell Cycle
DOI:10.1080/15384101.2021.1963910
影響因子 :5.2
引用產(chǎn)品: OV-90 細胞 , A2780 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , 人卵巢上皮細胞 , NIH:OVCAR-3 [OVCAR3]細胞專用培養(yǎng)基 , 人卵巢上皮細胞完全培養(yǎng)基 , OV-90細胞專用培養(yǎng)基
-
MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer (2021-04-17)
期刊:Gynecologic Oncology
DOI:10.1016/j.ygyno.2021.04.013
影響因子 :4.7
引用產(chǎn)品: A2780 細胞 , 人卵巢上皮細胞 , SK-OV-3 細胞 , ES-2 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis (2021-08-31)
期刊:Cell Cycle
DOI:10.1080/15384101.2021.1965723
影響因子 :4.3
引用產(chǎn)品: A2780 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , SK-BR-3 [SKBR3] 細胞
-
Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP (2021-01-16)
期刊:Journal of Cancer
影響因子 :3.9
引用產(chǎn)品: A2780 細胞 , SK-OV-3 細胞 , Hey 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞
-
miR?638 suppresses proliferation by negatively regulating high mobility group?A1 in ovarian cancer cells (2021-09-20)
期刊:Experimental and Therapeutic Medicine
影響因子 :2.7
引用產(chǎn)品: A2780 細胞 , ES-2 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , Caov-3 細胞
-
Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p (2020-02-24)
期刊:MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI:10.1007/s11010-020-03704-y
影響因子 :4.3
引用產(chǎn)品: ES-2 細胞 , McCoy's 5A 培養(yǎng)基 , NIH:OVCAR-3 [OVCAR3] 細胞
-
MiR-337–3p suppresses proliferation of epithelial ovarian cancer bytargeting PIK3CA and PIK3CB (2019-10-17)
期刊:Cancer Letters
DOI:10.1016/j.canlet.2019.10.021
影響因子 :9.7
引用產(chǎn)品: A2780 細胞 , 293T [HEK-293T] 細胞 , SK-OV-3 細胞 , NIH:OVCAR-3 [OVCAR3] 細胞 , ES-2 細胞
-
A 19F NMR probe for the detection of β-galactosidase: simple structure with low molecular weight of 274.2, “turn-on” signal without the background, and good performance applicable in cancer cell line (2017-06-28)
期刊:J Mater Chem B
影響因子 :7.6
引用產(chǎn)品: NIH:OVCAR-3 [OVCAR3] 細胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖